Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Materialtyp: Artikel
Språk:English
Publicerad: Wiley 2022-06-01
Serie:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Ämnen:
angiotensin receptor blockers
angiotensin‐converting enzyme inhibitors
calcium channel blockers
COVID‐19
renin‐aldosterone angiotensin system inhibitors
thiazide diuretics
Länkar:https://www.ahajournals.org/doi/10.1161/JAHA.122.025289

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.025289

Liknande verk